Cargando…

The Role of Community Pharmacists in Travel Health and Vaccination in Switzerland

This review presents the Swiss strategy initiated over the last several years to implement vaccination by community pharmacists. National health authorities aimed to integrate community pharmacists in the National Vaccination Strategy (NVS) in order to increase the vaccination rate in the Swiss popu...

Descripción completa

Detalles Bibliográficos
Autores principales: Leuthold, Claudine, Bugnon, Olivier, Berger, Jérôme
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6306781/
https://www.ncbi.nlm.nih.gov/pubmed/30501076
http://dx.doi.org/10.3390/pharmacy6040125
_version_ 1783382855749992448
author Leuthold, Claudine
Bugnon, Olivier
Berger, Jérôme
author_facet Leuthold, Claudine
Bugnon, Olivier
Berger, Jérôme
author_sort Leuthold, Claudine
collection PubMed
description This review presents the Swiss strategy initiated over the last several years to implement vaccination by community pharmacists. National health authorities aimed to integrate community pharmacists in the National Vaccination Strategy (NVS) in order to increase the vaccination rate in the Swiss population. To support this aim, universities and the Swiss Association of Pharmacists developed pre- and post-graduate education programmes on vaccination for pharmacists. Finally, each Swiss canton (sovereign for health-related aspects) set proper regulations to authorize pharmacists to vaccinate and to determine which vaccines could be administered. As of September 2018, 19 cantons (out of 26) had authorized influenza vaccinations under the sole responsibility of an accredited community pharmacist. Additional vaccinations were available in 13 cantons (e.g., tick-borne encephalitis or hepatitis A, B, or A and B). Such implementation in other countries should follow a similar top-down (following a national strategy to improve vaccination coverage) and stepwise (starting with influenza to demonstrate the competencies of community pharmacists) strategy, supported by the development of research, education and accreditation. The development of health advice related to travels in community pharmacies should follow the same development in Switzerland. Currently, it offers the opportunity for strengthening travellers’ safety, beyond vaccination issues.
format Online
Article
Text
id pubmed-6306781
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-63067812019-01-02 The Role of Community Pharmacists in Travel Health and Vaccination in Switzerland Leuthold, Claudine Bugnon, Olivier Berger, Jérôme Pharmacy (Basel) Review This review presents the Swiss strategy initiated over the last several years to implement vaccination by community pharmacists. National health authorities aimed to integrate community pharmacists in the National Vaccination Strategy (NVS) in order to increase the vaccination rate in the Swiss population. To support this aim, universities and the Swiss Association of Pharmacists developed pre- and post-graduate education programmes on vaccination for pharmacists. Finally, each Swiss canton (sovereign for health-related aspects) set proper regulations to authorize pharmacists to vaccinate and to determine which vaccines could be administered. As of September 2018, 19 cantons (out of 26) had authorized influenza vaccinations under the sole responsibility of an accredited community pharmacist. Additional vaccinations were available in 13 cantons (e.g., tick-borne encephalitis or hepatitis A, B, or A and B). Such implementation in other countries should follow a similar top-down (following a national strategy to improve vaccination coverage) and stepwise (starting with influenza to demonstrate the competencies of community pharmacists) strategy, supported by the development of research, education and accreditation. The development of health advice related to travels in community pharmacies should follow the same development in Switzerland. Currently, it offers the opportunity for strengthening travellers’ safety, beyond vaccination issues. MDPI 2018-11-29 /pmc/articles/PMC6306781/ /pubmed/30501076 http://dx.doi.org/10.3390/pharmacy6040125 Text en © 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Leuthold, Claudine
Bugnon, Olivier
Berger, Jérôme
The Role of Community Pharmacists in Travel Health and Vaccination in Switzerland
title The Role of Community Pharmacists in Travel Health and Vaccination in Switzerland
title_full The Role of Community Pharmacists in Travel Health and Vaccination in Switzerland
title_fullStr The Role of Community Pharmacists in Travel Health and Vaccination in Switzerland
title_full_unstemmed The Role of Community Pharmacists in Travel Health and Vaccination in Switzerland
title_short The Role of Community Pharmacists in Travel Health and Vaccination in Switzerland
title_sort role of community pharmacists in travel health and vaccination in switzerland
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6306781/
https://www.ncbi.nlm.nih.gov/pubmed/30501076
http://dx.doi.org/10.3390/pharmacy6040125
work_keys_str_mv AT leutholdclaudine theroleofcommunitypharmacistsintravelhealthandvaccinationinswitzerland
AT bugnonolivier theroleofcommunitypharmacistsintravelhealthandvaccinationinswitzerland
AT bergerjerome theroleofcommunitypharmacistsintravelhealthandvaccinationinswitzerland
AT leutholdclaudine roleofcommunitypharmacistsintravelhealthandvaccinationinswitzerland
AT bugnonolivier roleofcommunitypharmacistsintravelhealthandvaccinationinswitzerland
AT bergerjerome roleofcommunitypharmacistsintravelhealthandvaccinationinswitzerland